- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
January 13, 2022
This webinar reviewed the latest advances, opportunities and disappointments in HIV prevention and provided an opportunity to address key questions including: where we are with the introduction of injectable cabotegravir and the Dapivirine Vaginal Ring; the development status (including setbacks) of promising new PrEP agents; and how to ensure HIV prevention and equitable access to innovation do not fall further behind; and much more.
This webinar featured the perspectives of Linda-Gail Bekker from South Africa’s Desmond Tutu Health Foundation (and AVAC’s board); Grace Kumwenda of Pakachere Institute of Health and Development Communication in Malawi and Kenneth Mwehonge, the new executive director of Coalition for Health Promotion and Social Development (HEPS-Uganda) — both former AVAC Fellows — and Rachel Baggaley from the World Health Organization.